Article
Pancreatic Cancer: Genetics, Screening, Prevention, and Treatment.
The Surgical clinics of North America - 1 Aug 2026
Abul-Khoudoud Sami O, Hardacre Jeffrey M
Abstract excerpt
Pancreatic cancer is a highly lethal malignancy with an overall 5-year survival rate of just 13%, and its most common histologic subtype, pancreatic ductal adenocarcinoma (PDAC), carries an even poorer prognosis. Its aggressive nature is driven by complex genetic, epigenetic, and microenvironmental alterations. Key driver mutations in Kirsten rat sarcoma, cyclin-dependent kinase inhibitor 2A, TP53, and SMAD4...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
